Literature DB >> 8878570

Comparison of a spectrophotometric microdilution method with RPMI-2% glucose with the National Committee for Clinical Laboratory Standards reference macrodilution method M27-P for in vitro susceptibility testing of amphotericin B, flucytosine, and fluconazole against Candida albicans.

J L Rodríguez-Tudela1, J Berenguer, J V Martínez-Suárez, R Sanchez.   

Abstract

The National Committee for Clinical Laboratory Standards has proposed a reference broth macrodilution method for in vitro antifungal susceptibility testing of yeasts (the M27-P method). This method is cumbersome and time-consuming and includes MIC endpoint determination by visual and subjective inspection of growth inhibition after 48 h of incubation. An alternative microdilution procedure was compared with the M27-P method for determination of the amphotericin B, flucytosine, and fluconazole susceptibilities of 8 American Type Culture Collection strains (6 of them were quality control or reference strains) and 50 clinical isolates of candida albicans. This microdilution method uses as culture medium RPMI 1640 supplemented with 18 g of glucose per liter (RPMI-2% glucose). Preparation of drugs, basal medium, and inocula was done by following the recommendations of the National Committee for Clinical Laboratory Standards. The MIC endpoint was calculated objectively from the turbidimetric data read at 24 h. Increased growth of C. albicans in RPMI-2% glucose and its spectrophotometric reading allowed for the rapid (24 h) and objective calculation of MIC endpoints compared with previous microdilution methods with standard RPMI 1640. Nevertheless, good agreement was shown between the M27-P method and this microdilution test. The MICs obtained for the quality control or reference strains by the microdilution method were in the ranges published for those strains. For clinical isolates, the percentages of agreement were 100% for amphotericin B and fluconazole and 98.1% for flucytosine. These data suggest that this microdilution method may serve as a less subjective and more rapid alternative to the M27-P method for antifungal susceptibility testing of yeasts.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8878570      PMCID: PMC163462     

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  20 in total

1.  Collaborative comparison of broth macrodilution and microdilution antifungal susceptibility tests.

Authors:  A Espinel-Ingroff; C W Kish; T M Kerkering; R A Fromtling; K Bartizal; J N Galgiani; K Villareal; M A Pfaller; T Gerarden; M G Rinaldi
Journal:  J Clin Microbiol       Date:  1992-12       Impact factor: 5.948

Review 2.  Antifungal susceptibility testing.

Authors:  J H Rex; M A Pfaller; M G Rinaldi; A Polak; J N Galgiani
Journal:  Clin Microbiol Rev       Date:  1993-10       Impact factor: 26.132

3.  Secular trends in the epidemiology of nosocomial fungal infections in the United States, 1980-1990. National Nosocomial Infections Surveillance System.

Authors:  C Beck-Sagué; W R Jarvis
Journal:  J Infect Dis       Date:  1993-05       Impact factor: 5.226

4.  Secular trends in nosocomial primary bloodstream infections in the United States, 1980-1989. National Nosocomial Infections Surveillance System.

Authors:  S N Banerjee; T G Emori; D H Culver; R P Gaynes; W R Jarvis; T Horan; J R Edwards; J Tolson; T Henderson; W J Martone
Journal:  Am J Med       Date:  1991-09-16       Impact factor: 4.965

5.  Antimicrobial susceptibility testing of yeasts: a turbidimetric technique independent of inoculum size.

Authors:  J N Galgiani; D A Stevens
Journal:  Antimicrob Agents Chemother       Date:  1976-10       Impact factor: 5.191

6.  Comparison of two alternative microdilution procedures with the National Committee for Clinical Laboratory Standards reference macrodilution method M27-P for in vitro testing of fluconazole-resistant and -susceptible isolates of Candida albicans.

Authors:  A Espinel-Ingroff; J L Rodríguez-Tudela; J V Martínez-Suárez
Journal:  J Clin Microbiol       Date:  1995-12       Impact factor: 5.948

7.  Comparison study of broth macrodilution and microdilution antifungal susceptibility tests.

Authors:  A Espinel-Ingroff; T M Kerkering; P R Goldson; S Shadomy
Journal:  J Clin Microbiol       Date:  1991-06       Impact factor: 5.948

Review 8.  Emerging fungal pathogens.

Authors:  E J Anaissie; G P Bodey; M G Rinaldi
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1989-04       Impact factor: 3.267

9.  Improved medium for fluconazole susceptibility testing of Candida albicans.

Authors:  J L Rodriguez-Tudela; J V Martinez-Suarez
Journal:  Antimicrob Agents Chemother       Date:  1994-01       Impact factor: 5.191

10.  Fluconazole susceptibility testing of Candida albicans: microtiter method that is independent of inoculum size, temperature, and time of reading.

Authors:  E Anaissie; V Paetznick; G P Bodey
Journal:  Antimicrob Agents Chemother       Date:  1991-08       Impact factor: 5.191

View more
  12 in total

1.  Standardization of antifungal susceptibility variables for a semiautomated methodology.

Authors:  J L Rodríguez-Tudela; M Cuenca-Estrella; T M Díaz-Guerra; E Mellado
Journal:  J Clin Microbiol       Date:  2001-07       Impact factor: 5.948

2.  Azasordarins: susceptibility of fluconazole-susceptible and fluconazole-resistant clinical isolates of Candida spp. to GW 471558.

Authors:  M Cuenca-Estrella; E Mellado; T M Díaz-Guerra; A Monzón; J L Rodríguez-Tudela
Journal:  Antimicrob Agents Chemother       Date:  2001-06       Impact factor: 5.191

3.  Influence of shaking on antifungal susceptibility testing of Cryptococcus neoformans: a comparison of the NCCLS standard M27A medium, buffered yeast nitrogen base, and RPMI-2% glucose.

Authors:  J L Rodríguez-Tudela; F Martín-Díez; M Cuenca-Estrella; L Rodero; Y Carpintero; B Gorgojo
Journal:  Antimicrob Agents Chemother       Date:  2000-02       Impact factor: 5.191

4.  Influence of incubation time, inoculum size, and glucose concentrations on spectrophotometric endpoint determinations for amphotericin B, fluconazole, and itraconazole.

Authors:  M H Nguyen; C Y Yu
Journal:  J Clin Microbiol       Date:  1999-01       Impact factor: 5.948

5.  Influence of glucose supplementation and inoculum size on growth kinetics and antifungal susceptibility testing of Candida spp.

Authors:  M Cuenca-Estrella; T M Díaz-Guerra; E Mellado; J L Rodríguez-Tudela
Journal:  J Clin Microbiol       Date:  2001-02       Impact factor: 5.948

6.  Selection of Candida glabrata strains with reduced susceptibility to azoles in four liver transplant patients with invasive candidiasis.

Authors:  J Fortún; A López-San Román; J J Velasco; A Sánchez-Sousa; E de Vicente; J Nuño; C Quereda; R Bárcena; G Monge; A Candela; A Honrubia; A Guerrero
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1997-04       Impact factor: 3.267

7.  In vitro antifungal activity and cytotoxicity of a novel membrane-active peptide.

Authors:  S Y Hong; J E Oh; K H Lee
Journal:  Antimicrob Agents Chemother       Date:  1999-07       Impact factor: 5.191

8.  Quantitation of ergosterol content: novel method for determination of fluconazole susceptibility of Candida albicans.

Authors:  B A Arthington-Skaggs; H Jradi; T Desai; C J Morrison
Journal:  J Clin Microbiol       Date:  1999-10       Impact factor: 5.948

9.  Aromatic cyclic peroxides and related keto-compounds from the Plakortis sp. component of a sponge consortium.

Authors:  Emiliano Manzo; M Letizia Ciavatta; Dominique Melck; Peter Schupp; Nicole de Voogd; Margherita Gavagnin
Journal:  J Nat Prod       Date:  2009-08       Impact factor: 4.050

10.  Identification and characterization of novel antimicrobial decapeptides generated by combinatorial chemistry.

Authors:  S Y Hong; J E Oh; M Kwon; M J Choi; J H Lee; B L Lee; H M Moon; K H Lee
Journal:  Antimicrob Agents Chemother       Date:  1998-10       Impact factor: 5.191

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.